Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-24T09:36:23.327Z Has data issue: false hasContentIssue false

When Should Contact Precautions and Active Surveillance Be Used to Manage Patients with Multidrug-Resistant Enterobacteriaceae?

Published online by Cambridge University Press:  02 January 2015

Joshua T. Freeman*
Affiliation:
Department of Microbiology and Infection Prevention and Control, Auckland City Hospital, Auckland, New Zealand
Deborah A. Williamson
Affiliation:
Department of Microbiology and Infection Prevention and Control, Auckland City Hospital, Auckland, New Zealand
Deverick J. Anderson
Affiliation:
Duke Infection Control Outreach Network, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
*
Department of Microbiology, LabPlus, Auckland City Hospital, 2 Grafton Road, Auckland, New Zealand (JoshuaF@adhb.govt.nz)

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Peleg, A, Hooper, D. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:18041813.Google Scholar
2. Chen, YH, Hsueh, PR, Badai, RE, et al. Antimicrobial susceptibility profiles of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011;62(4):280291.Google Scholar
3. Canton, R, Coque, TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006;9:466475.Google Scholar
4. Carratoli, A. Resistance plasmid families in Enterobacteriaceae . Antimicrob Agents Chemother 2009;53:22272238.Google Scholar
5. Woodford, N. Successful, multiresistant bacterial clones. J Antimicrob Chemother 2008;61:233234.CrossRefGoogle ScholarPubMed
6. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Atlanta: Centers for Disease Control and Prevention, 2007.Google Scholar
7. Srinivasan, A, Song, X, Ross, T, et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002;23: 424428.CrossRefGoogle Scholar
8. Snyder, GM, Thorn, KA, Furuno, JP, et al. Detection of methi-cillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol 2008;29:583589.CrossRefGoogle ScholarPubMed
9. Aboelela, SW, Saiman, L, Stone, P, et al. Effectiveness of barrier precautions and active surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control 2006;34:484494.Google Scholar
10. Spence, MR, Dammel, T, Courser, S. Contact precautions for meth-icillin-resistant Staphylococcus aureus colonization: costly and unnecessary? Am J Infect Control doi:10.1016/j.ajic.2011.07.016. Published October 19, 2011.Google Scholar
11. Langer, AJ, Lafaro, P, Genese, CA, McDonough, P, Nahass, R, Robertson, C. Using active surveillance and enhanced infection control measures to control an outbreak of health care-associated extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections—New Jersey, 2007. Am J Infect Control 2009;37:7375.CrossRefGoogle ScholarPubMed
12. Laurent, C, Rodriguez-Villabos, H, Rost, F, et al. Intensive care unit outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008;29:517524.CrossRefGoogle ScholarPubMed
13. Kola, A, Holst, M, Chaberny, S, Ziesing, S, Suerbaum, S, Gastmeier, P. Surveillance of extended-spectrum (β-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007;66:4651.CrossRefGoogle ScholarPubMed
14. Conterno, LO, Shymanski, J, Ramotar, K, Toye, B, Zvonar, R, Roth, V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum β-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007;65:354360.Google Scholar
15. Morgan, DJ, Diekema, DJ, Sepkowitz, K, Perencevich, EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009;37:8593.Google Scholar
16. Thouverez, M, Talon, D, Bertrand, X. Control of Enterobacteri-aceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004;25:838841.CrossRefGoogle Scholar
17. Kumarasamy, KK, Toleman, MA, Walsh, TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597602.CrossRefGoogle Scholar
18. Laupland, KB, Kirkpatrick, AW, Church, DL, Ross, T, Gregson, DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 2004;58:137145.Google Scholar
19. Harris, AD, McGregor, JC, Furano, JP. What infection control interventions should be undertaken to control multidrug-resis-tant gram-negative bacteria? Clin Infect Dis 2006;43:S57S61.Google Scholar
20. Gardam, MA, Burrows, LL, Kus, JV, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 2002; 186:17541760.CrossRefGoogle ScholarPubMed
21. Anderson, B, Nicholas, S, Sprague, B, et al. Molecular and descriptive epidemiology of multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol 2008; 29:250255.Google Scholar
22. Harris, AD, Koteshvili, M, Shurland, S, et al. How important is patient-to-patient transmission in extended-spectrum β-lacta-mase Escherichia coli acquisition? Am J Infect Control 2007;35: 97101.Google Scholar
23. Harris, AD, Perencevich, EN, Johnson, JK, et al. Patient-to-patient transmission is important in extended-spectrum β-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007;45; 13471350.Google Scholar
24. Freeman, JT, McBride, SJ, Heffernan, H, et al. Community-onset genitourinary tract infection due to CTX-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 2008;47:689692.CrossRefGoogle Scholar
25. Ben Ami, R, Schwaber, MJ, Nanon-Venezia, S, et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925934.Google Scholar
26. Tângdén, T, Cars, O, Melhus, A, Löwdin, E. Foreign travel is a major risk factor for colonization with Escherichia SHV1 producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010;54:35643568.Google Scholar
27. Calbo, E, Friexas, N, Xercavins, M, et al. Foodborne nosocomial outbreak of SHV1 and CTX-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 2011; 52:743749.CrossRefGoogle Scholar
28. Gaillot, O, Marueiouls, C, Abachin, E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum /3-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:13571360.CrossRefGoogle Scholar
29. Gupta, A, Delia-Latta, P, Todd, B, et al. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004;25:210215.CrossRefGoogle Scholar
30. Hota, B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004;39:11821189.Google Scholar
31. Hirai, Y. Survival of bacteria under dry conditions: from a viewpoint of nosocomial infection. J Hosp Infect 1991;19:191200.CrossRefGoogle ScholarPubMed
32. Lemmen, SW, Haifner, H, Zolldan, D, Stanzel, S, Lutticken, R. Distribution of multi-resistant gram-negative bacteria versus gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 2004;56:191197.CrossRefGoogle ScholarPubMed
33. Kirkland, KB. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009;48: 766771.CrossRefGoogle Scholar
34. Diekema, DJ, Edmond, MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007; 44:11011107.Google ScholarPubMed
35. Fuller, C, Savage, J, Besser, S, et al. “The dirty hand in the latex glove”: a study of hand hygiene compliance when gloves are worn. Infect Control Hosp Epidemiol 2011;32:11941199.CrossRefGoogle ScholarPubMed
36. Wenzel, RR Minimizing surgical site infections. N Engl J Med 2010;362:7577.Google Scholar
37. Gasink, LB, Brennan, PJ. Isolation precautions for antibiotic-resistant bacteria in healthcare settings. Curr Opin Infect Dis 2009;22:339344.Google Scholar